Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems
JAMA · 12.11.2024 · 332 (18) · 1578
DOI: 10.1001/jama.2024.18575 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 12.11.2024. Verfasst von Lina Steinrud Mørch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study uses data from nationwide Danish registries to assess breast cancer risk with continuous use of levonorgestrel-releasing intrauterine systems, accounting for other hormonal exposures.
Autor:innen und Institutionen
- Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark.
- Statistics and Data Analysis, The Danish Cancer Institute, Copenhagen, Denmark.
- Virus, Lifestyle and Genes, The Danish Cancer Institute, Copenhagen, Denmark.
Zitieren
APA
Mørch, L. S., Meaidi, A., Corn, G., Hargreave, M., & Wessel Skovlund, C. (2024). Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA, 332(18), 1578. https://doi.org/10.1001/jama.2024.18575
Vancouver
Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578. doi:10.1001/jama.2024.18575
BibTeX
@article{Mrch2024,
author = {Mørch, Lina Steinrud and Meaidi, Amani and Corn, Giulia and Hargreave, Marie and Wessel Skovlund, Charlotte},
title = {Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems},
journal = {JAMA},
year = {2024},
volume = {332},
number = {18},
pages = {1578},
doi = {10.1001/jama.2024.18575}
}
EUVIMED